WDR5 and leukemia: We recently described a set of potent small molecule inhibitors against the WDR5-interaction (WIN) site of WDR5.3 These inhibitors were discovered with the intent of driving changes in histone H3 methylation that would cause certain leukemia cells to differentiate or die.